Galetzka, D., Böck, J., Wagner, L., Dittrich, M., Sinizyn , O., Ludwig, M., Rossmann, H., Spix, C., Radsak, M., Scholz-Kreisel, P., Mirsch, J., Linke, M., Brenner, W., Marron, M., Poplawski, A., Haaf, T., Schmidberger, H. and Prawitt, D. 2022. Hypermethylation of RAD9A intron 2 in childhood cancer patients, leukemia and tumor cell lines suggest a role for oncogenic transformation. EXCLI Journal. 21, (Jan. 2022), 117–143. DOI:https://doi.org/10.17179/excli2021-4482.